Related Experiment Video
Updated: May 16, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Thromboprophylaxis in nonsurgical patients
Michael B Streiff1, Brandyn D Lau
1Division of Hematology, Department of Medicine and Associate Faculty, Armstrong Institute of Patient Safety and Quality Care, Johns Hopkins University School of Medicine, 1830 E MonumentSt, Ste 7300, Baltimore, MD 21205, USA. mstreif@jhmi.edu
Hematology. American Society of Hematology. Education Program
|December 13, 2012
Summary
Pharmacologic prophylaxis effectively prevents venous thromboembolism (VTE) in medically ill patients. Low-molecular-weight heparin is preferred over unfractionated heparin due to less bleeding, while new risk tools and extended prophylaxis warrant further study.
Area of Science:
- Internal Medicine
- Hematology
- Critical Care Medicine
Background:
- Venous thromboembolism (VTE) is a significant cause of preventable harm in hospitalized patients.
- Pharmacologic prophylaxis is a key strategy to reduce VTE events.
Purpose of the Study:
- To review the efficacy and safety of pharmacologic VTE prophylaxis in medically ill patients.
- To discuss emerging risk stratification tools and alternative prophylaxis methods.
Main Methods:
- Systematic review of randomized controlled trials comparing pharmacologic prophylaxis versus placebo or other interventions.
- Analysis of comparative effectiveness and safety data for different anticoagulant agents and mechanical devices.
Main Results:
- Pharmacologic prophylaxis significantly reduces deep vein thrombosis and pulmonary embolism.
- Low-molecular-weight heparin (LMWH) shows similar efficacy to unfractionated heparin but with less major bleeding.
- Intermittent pneumatic compression devices are recommended for patients with contraindications to pharmacologic prophylaxis.
Conclusions:
- LMWH is favored for VTE prophylaxis in critically ill patients.
- Novel risk stratification tools and extended-duration prophylaxis require further investigation.
- Improving VTE prophylaxis adherence requires multidisciplinary performance improvement initiatives.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...